KIRs and HLA ligands are polymorphic and diverse immune protection by the multiplicity of functional compound KIR-HLA genotypes through NK cell activity has been observed after curative HCC resection [15]. The gene discussed is KIR3DL1; the disease is hepatocellular carcinoma.